 |
|
|
|
 |
|
|
| Article 1 to 10 out of 12 concerning Millipore Corporation
|
-
Millipore Forms Collaboration with Agilent Technologies to Expand Capabilities in Epigenetics Research Market
(09/05/2008)
Millipore Corporation and Agilent Technologies Inc. announced they have formed a collaboration to develop ChIP (chromatin immunoprecipitation) kits for the fast-growing epigenetics research market. The kits will be designed to improve protein ...
-
Millipore and Novo Nordisk Expand Agreement to Supply Biopharmaceutical Market with Recombinant Human Insulin
(08/17/2007)
Millipore gains long-term exclusive worldwide rights to distribute Novo Nordisk's insulin for cell culture applications
Millipore Corporation announced an expansion of its agreement with Novo Nordisk to provide the biopharmaceutical market with recombinant human insulin, a key cell culture supplement used to manufacture biologic drugs. Under the terms of the ...
-
Millipore Becomes First Company to Embed RFID Technology in Filtration Products Used for Biopharmaceutical Manufacturing
(04/17/2007)
Millipore Corporation announced that it is the first company to successfully integrate Radio Frequency Identification (RFID) technology with filtration products used to manufacture biopharmaceutical drugs. The new RFID capability will be branded as ...
-
Millipore and Stem Cell Sciences To Provide Human Embryonic Stem Cell Media
(10/27/2006)
Millipore Corporation and Stem Cell Sciences (SCS) announced an exclusive license for Millipore to develop and market SCS' serum free media for the growth of human embryonic stem cells (hESCs). According to the company, the defined media will be the ...
-
Millipore Corporation to Acquire Serologicals
(04/27/2006)
Millipore Corporation and Serologicals Corporation announced that their boards of directors have approved a definitive agreement whereby Millipore will acquire Serologicals in an all cash transaction. The acquisition will transform Millipore into a ...
-
Millipore Acquires NovAseptic AB: Broadens Offering to Biotech and Pharmaceutical Industry
(08/11/2005)
Millipore Corporation announced that it has completed the acquisition of over 90% of the shares of NovAseptic AB from the company's majority shareholders. Millipore is in the process of acquiring the remaining shares from the minority ...
-
Millipore Acquires European Contract Testing Lab
(07/07/2005)
Acquisition Adds Expertise in Virus, Mycoplasma and Bacteria Testing and Strengthens Millipore's Growing Services Business
Millipore Corporation announced it has completed the acquisition of MicroSafe, B.V., for approximately $9.3M. MicroSafe is a contract laboratory that develops assays and provides a range of testing services to help leading European biotech and ...
-
Millipore Opens New State-of-the-Art Manufacturing Facility
(08/23/2004)
$29 million investment in the future of biotechnology
Millipore Corporation announced the official opening of its new $29 million state-of-the-art membrane casting manufacturing facility in Jaffrey, New Hampshire. Adjacent to Millipore's current device plant on Prescott Road, the 44,000-square-foot ...
-
Millipore Obtains Patent Rights for Sequencing Reaction Clean-up from Japanese Research Institute
(06/21/2002)
BEDFORD, Mass. and SAITAMA, Japan, Jun 19, 2002 - Millipore Corporation announced today a license agreement with RIKEN (The Institute of Physical and Chemical Research) granting Millipore exclusive rights to RIKEN's patent (U.S. Patent no. ...
-
Millipore Acquires Rights to Disposable Manufacturing Technology for Biopharmaceutical Production
(04/09/2002)
Bedford, Massachusetts, – Millipore Corporation announced it has acquired rights to new technology that enables the sterile filling of biopharmaceutical drugs in a closed, disposable system. The technology was licensed on an exclusive basis for ...
|
|
|
|
|
Top